Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 11—November 2012
Research

HIV Infection and Geographically Bound Transmission of Drug-Resistant Tuberculosis, Argentina

Viviana RitaccoComments to Author , Beatriz López, Marta Ambroggi, Domingo Palmero, Bernardo Salvadores, Elida Gravina, Eduardo Mazzeo, Susana Imaz, Lucía Barrera, and National TB Laboratory Network
Author affiliations: Instituto Nacional de Enfermedades Infecciosas ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina (V. Ritacco, B. López, E. Mazzeo, L. Barrera); Hospital “Dr. F.J. Muñiz,” Buenos Aires (M. Ambroggi, D. Palmero); Programa Provincial de Tuberculosis, Santa Fe, Argentina (B. Salvadores); Hospital Zonal General Agudos “Dr. Diego Paroissien,” La Matanza, Argentina (E. Gravina); and Instituto Nacional de Enfermedades Respiratorias “Dr. Emilio Coni” ANLIS “Dr Carlos G Malbran,” Santa Fe (S. Imaz)

Main Article

Table 2

Predictors for being in cluster and in major cluster for 787 patients with multidrug-resistant TB, Argentina, 2003–2009*

Characteristic No. patients % Patients in cluster Unadjusted OR (95% CI) Adjusted OR (95% CI)† % Patients in major cluster‡ Unadjusted OR (95% CI) Adjusted OR (95% CI)§
Age, y, n = 640

<15

24 83.3 2.9 (0.9–8.9) ND 58.3 1.5 (0.6–3.6) ND

16–45

495 78.6 2.1 (1.4–3.2) 2.5 (1.3–5.0) 57.9 1.5 (1.0–2.2) 1.0 (0.5–2.0)

>45

121 63.6 1 1 48.3 1 1
Country of birth, n = 541

Argentina

412 80.1 2.7 (1.7–3.9) 3.5 (1.9–6.4) 66.7 7.6 (4.7–12.1) 8.0 (4.3–15.0)

Other

129 61.2 1 1 20.9 1 1
Place of diagnosis, n = 787

Hotspot¶

634 77.9 2.1 (1.5–3.1) 1.6 (0.7–3.7) 62.3 4.2 (2.9–6.2) 5.9 (2.5–13.8)

Other

153 62.1 1 1 28.1 1 1
HIV status, n = 604

Positive

254 86.6 2.7 (1.7–4.1) 2.4 (1.0–5.6) 76.4 3.3 (2.-4.7) 3.7 (1.8–7.7)

Negative

350 70.9 1 1 49.4 1 1
Previous TB, n = 557

Yes

313 71.9 0.7 (0.5–1.0) 0.8 (0.5–1.5) 51.8 0.7 (0.5–1.0) 0.7 (0.4–1.2)

No

244 79.1 1 1 59.4 1 1
Site of disease, n = 775

Pulmonary only

698 74.1 0.6 (0.3–1.2) 1.4 (0.5–4.2) 55.0 0.8 (0.5–1.3) 2.7 (1.1–7.0)

Other

77 81.8 1 1 59.7 1 1

*Boldface indicates significance. TB, tuberculosis; OR, odds ratio; ND, not done.
†Cluster model overall model fit p < 0.0001, Hosmer & Lemeshow test p = 0.5888, area under the receiver operating characteristic curve 0.723.
‡Cluster including >15 patients in the study period.
§Major cluster model overall model fit p < 0.0001, Hosmer & Lemeshow test p = 0.7766, area under the receiver operating characteristic curve 0.793.
¶Area where a multidrug-resistant outbreak was previously documented.

Main Article

1Additional members of the National TB Laboratory Network who contributed data are listed at the end of this article.

Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external